Skip to main content
. 2020 May 11;48(5):0300060520904835. doi: 10.1177/0300060520904835

Figure 4.

Figure 4.

CCK-8 test of the viability of MCs. a: Viability of MCs in the MCs + H/R, MCs + Tm, L/M + H/R, L/M + Tm, and untreated control groups. b: Viability of MCs with Ad-CREBHi and Ad-USi. Note: *P < 0.05 vs the control group.

Tm: tunicamycin, H/R: hypoxia/reperfusion, MCS: myocardial cells, L/M: lower compartment and hepatocytes, Ad-USi: adenovirus for the unspecific, Ad-CREBHi: adenovirus for cyclic AMP-responsive element-binding protein H (CREBH) RNAi.